Obesity biotech Kailera Therapeutics has successfully entered the US public market with an upsized $625 million Initial Public Offering (IPO),...
Roche has finalized a definitive agreement to acquire Saga Diagnostics, a specialist in ultra-sensitive molecular residual disease (MRD) testing, in...
Boehringer Ingelheim has officially inaugurated a new artificial intelligence (AI) and machine learning (ML) center in London, marking a significant...
ScreenPoint Medical, a prominent developer of artificial intelligence (AI) solutions for breast imaging, has successfully closed a $16 million funding...
Boehringer Ingelheim, a leading research-driven pharmaceutical company, has officially inaugurated a significant new artificial intelligence (AI) and machine learning (ML)...